Abstract
Objective:
The aim of this study was to assess the genetic effects of the vascular endothelial growth factor (VEGF) pathway on retinopathy of prematurity (ROP).
Study Design:
A prospective study from a tertiary center that enrolled 204 Japanese infants (<35 weeks of gestational age (GA)) having no anomalies. ROP developed in 127, but not in 77 infants. The relative severity was defined as non-severe, moderate and severe ROP for GA, based on the staging criteria. VEGF (g.−634G>C, g.+13553C>T) and VEGF-receptor (KDR g.+4422(AC)11 to 14, Flt-1 c.+6724(TG)13 to 23) gene polymorphisms and clinical variables were assessed by uni/multivariate analyses.
Result:
The frequency of polymorphisms did not differ between ROP and non-ROP patients. The TT genotype of g.+13553 showed a higher odds ratio for non-severe ROP than CC genotype (P=0.006). Multivariate analyses indicated that low birth weight, blood transfusion and respiratory distress syndrome, but not polymorphisms, were the risk factors of advanced ROP (⩾stage 3).
Conclusion:
A genotype of the VEGF pathway weakly affects the severity of ROP compared with other clinical factors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Chen J, Smith LE . Retinopathy of prematurity. Angiogenesis 2007; 10: 133–140.
Errera FI, Canani LH, Silva ME, Yeh E, Takahashi W, Santos KG et al. Functional vascular endothelial growth factor -634G>C SNP is associated with proliferative diabetic retinopathy: a case-control study in a Brazilian population of European ancestry. Diabetes Care 2007; 30: 275–279.
Lin JM, Wan L, Tsai YY, Lin HJ, Tsai Y, Lee CC et al. Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration. Am J Ophthalmol 2008; 145: 1045–1051.
Cooke RW, Drury JA, Mountford R, Clark D . Genetic polymorphisms and retinopathy of prematurity. Invest Ophthalmol Vis Sci 2004; 45: 1712–1715.
Vannay A, Dunai G, Bányász I, Szabó M, Vámos R, Treszl A et al. Association of genetic polymorphisms of vascular endothelial growth factor and risk for proliferative retinopathy of prematurity. Pediatr Res 2005; 57: 396–398.
Dunai G, Vásárhelyi B, Szabó M, Hajdú J, Mészáros G, Tulassay T et al. Published genetic variants in retinopathy of prematurity: random forest analysis suggests a negligible contribution to risk and severity. Curr Eye Res 2008; 33: 501–505.
Shastry BS, Qu X . Lack of association of the VEGF gene promoter (-634 G → C and -460 C → T) polymorphism and the risk of advanced retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2007; 245: 741–743.
Arrøe M, Peitersen B . Retinopathy of prematurity: review of a seven-year period in a Danish neonatal intensive care unit. Acta Paediatr 1994; 83: 501–505.
Karna P, Muttineni J, Angell L, Karmaus W . Retinopathy of prematurity and risk factors: a prospective cohort study. BMC Pediatr 2005; 5: 18–25.
Zaw W, Gagnon R, Silva O . The risks of adverse neonatal outcome among preterm small for gestational age infants according to neonatal versus fetal growth standards. Pediatrics 2003; 111: 1273–1277.
Yang MB, Donovan EF, Wagge JR . Race, gender, and clinical risk index for babies (CRIB) score as predictors of severe retinopathy of prematurity. J AAPOS 2006; 10: 253–261.
Akkoyun I, Oto S, Yilmaz G, Gurakan B, Tarcan A, Anuk D et al. Risk factors in the development of mild and severe retinopathy of prematurity. J AAPOS 2006; 10: 449–453.
Prepared by an International Committee. An international classification of retinopathy of prematurity. Br J Ophthalmol 1984; 68: 690–697.
Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E . A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000; 37: 443–448.
Kariyazono H, Ohno T, Khajoee V, Ihara K, Kusuhara K, Kinukawa N et al. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki Disease. Pediatr Res 2004; 56: 953–959.
Parry RG, Gillespie KM, Clark AG, Mathieson PW . Dinucleotide repeat polymorphisms within the Flt-1 gene in minimal change nephropathy. Eur J Immunogenet 1999; 26: 321–323.
Kwinta P, Bik-Multanowski M, Mitkowska Z, Tomasik T, Pietzyk JJ . The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1467–1475.
Mandal K, Drury JA, Clark DI . An unusual case of retinopathy of prematurity. J Perinatol 2007; 27: 315–316.
Pieh C, Agostini H, Buschbeck C, Krüger M, Schulte-Mönting J, Zirrgiebel U et al. VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity. Br J Ophthalmol 2008; 92: 689–693.
Madan A, Penn JS . Animal models of oxygen-induced retinopathy. Front Biosci 2003; 8: d1030–d1043.
Acknowledgements
We thank Dr Naoko Kinukawa (Department of Medical Informatics, Kyushu University Hospital, Fukuoka, Japan) and Dr Kazuo Sato (Division of Pediatrics, Kyushu National Medical Center, Fukuoka, Japan) for the statistical assistance and helpful discussion. This research was supported by a Grant-in-Aid for Scientific Research to Hikino S, Takahata Y and Ohga S from the Ministry of Education, Science, Sports and Culture of Japan.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Kusuda, T., Hikino, S., Ohga, S. et al. Genetic variation of vascular endothelial growth factor pathway does not correlate with the severity of retinopathy of prematurity. J Perinatol 31, 246–250 (2011). https://doi.org/10.1038/jp.2010.111
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2010.111
Keywords
This article is cited by
-
Retinopathy of prematurity: contribution of inflammatory and genetic factors
Molecular and Cellular Biochemistry (2022)
-
Lack of association of VEGF gene 3’- UTR polymorphisms (C702T, C936T and G1612A) and the risk of developing advanced retinopathy of prematurity (ROP)
Graefe's Archive for Clinical and Experimental Ophthalmology (2013)
-
Association of VEGF gene polymorphisms with advanced retinopathy of prematurity: a meta-analysis
Molecular Biology Reports (2012)